focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Regulatory News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - SHIRE PLC

20 Dec 2018 10:32

RNS Number : 1260L
Morgan Stanley & Co. Int'l plc
20 December 2018
 

 

 FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley & Co. International plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Shire plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Shire plc

(d) Date dealing undertaken:

19 DECEMBER 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes - Takeda Pharmaceutical Company Limited

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

 The currency of all prices and other monetary amounts should be stated.

 

 

(a) Purchases and sales

 

 Class of

relevant

security

 Purchases/

sales

 Total number

of securities

 Highest price

per unit paid/received

 Lowest price

per unit paid/received

 5p ordinary

 PURCHASES

 375

 48.9000 EUR

 48.9000 EUR

 

 5p ordinary

 SALES

 375

 48.9000 EUR

 48.9000 EUR

 

 5p ordinary

 PURCHASES

 5,154,394

 44.6900 GBP

 43.7100 GBP

 

 5p ordinary

 SALES

 2,532,883

 44.6850 GBP

 43.8206 GBP

 

 5p ordinary

 PURCHASES

 169,085

 56.3442 USD

 55.8617 USD

 

 5p ordinary

 SALES

 106,869

 56.1193 USD

 56.0463 USD

 

 

 

(b) Cash-settled derivative transactions

 

 Class of

relevant

security

 Product description

e.g. CFD

 Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 Number of reference securities

 Price per

unit

 ADR

 CFD

 LONG

 15,500

 168.0691 USD

 

 ADR

 CFD

 LONG

 300

 168.1700 USD

 

 ADR

 CFD

 LONG

 100

 168.5200 USD

 

 ADR

 CFD

 LONG

 100

 168.8750 USD

 

 5p ordinary

 CFD

 LONG

 105,062

 43.8206 GBP

 

 5p ordinary

 CFD

 LONG

 30,145

 43.8206 GBP

 

 5p ordinary

 CFD

 LONG

 1,599

 43.8206 GBP

 

 5p ordinary

 CFD

 LONG

 953

 43.8206 GBP

 

 5p ordinary

 CFD

 LONG

 7,764

 43.8206 GBP

 

 5p ordinary

 CFD

 LONG

 346

 43.8206 GBP

 

 5p ordinary

 CFD

 LONG

 1,410

 44.3200 GBP

 

 5p ordinary

 CFD

 LONG

 37,999

 44.3610 GBP

 

 5p ordinary

 CFD

 LONG

 2,449

 44.3610 GBP

 

 5p ordinary

 CFD

 LONG

 42,455

 44.3610 GBP

 

 5p ordinary

 CFD

 LONG

 8,430

 44.3610 GBP

 

 5p ordinary

 CFD

 LONG

 10,238

 44.3610 GBP

 

 5p ordinary

 CFD

 LONG

 36,314

 44.3610 GBP

 

 5p ordinary

 CFD

 LONG

 8,230

 44.3610 GBP

 

 5p ordinary

 CFD

 LONG

 200,000

 44.4279 GBP

 

 5p ordinary

 CFD

 LONG

 170

 44.4634 GBP

 

 5p ordinary

 CFD

 LONG

 20,000

 44.4682 GBP

 

 5p ordinary

 CFD

 LONG

 75,000

 44.4682 GBP

 

 5p ordinary

 CFD

 SHORT

 282

 44.0132 GBP

 

 5p ordinary

 CFD

 SHORT

 80,000

 44.2827 GBP

 

 5p ordinary

 CFD

 SHORT

 136

 44.3056 GBP

 

 5p ordinary

 CFD

 SHORT

 6,126

 44.3177 GBP

 

 5p ordinary

 CFD

 SHORT

 3,471

 44.3177 GBP

 

 5p ordinary

 CFD

 SHORT

 50,953

 44.3200 GBP

 

 5p ordinary

 CFD

 SHORT

 12,583

 44.3200 GBP

 

 5p ordinary

 CFD

 SHORT

 12,583

 44.3200 GBP

 

 5p ordinary

 CFD

 SHORT

 179,000

 44.3577 GBP

 

 5p ordinary

 CFD

 SHORT

 157,425

 44.3710 GBP

 

 5p ordinary

 CFD

 SHORT

 208,578

 44.3728 GBP

 

 5p ordinary

 CFD

 SHORT

 154,118

 44.3821 GBP

 

 5p ordinary

 CFD

 SHORT

 457,820

 44.3933 GBP

 

 5p ordinary

 CFD

 SHORT

 4,940

 44.4675 GBP

 

 5p ordinary

 CFD

 LONG

 1,996

 44.3150 GBP

 

 5p ordinary

 CFD

 LONG

 90,000

 56.2478 USD

 

 5p ordinary

 CFD

 SHORT

 61,730

 55.8338 USD

 

 5p ordinary

 CFD

 SHORT

 17,980

 55.8617 USD

 

 5p ordinary

 CFD

 SHORT

 350

 55.8617 USD

 

 5p ordinary

 CFD

 SHORT

 8,584

 56.0404 USD

 

 5p ordinary

 CFD

 SHORT

 4,416

 56.0404 USD

 

 5p ordinary

 CFD

 SHORT

 89,400

 56.0808 USD

 

 5p ordinary

 CFD

 SHORT

 50,000

 56.1631 USD

 

 5p ordinary

 CFD

 SHORT

 55,000

 56.1665 USD

 

 5p ordinary

 CFD

 SHORT

 5,800

 56.2011 USD

 

 5p ordinary

 CFD

 SHORT

 2,700

 56.2011 USD

 

 5p ordinary

 CFD

 SHORT

 2,132

 56.2011 USD

 

 5p ordinary

 CFD

 SHORT

 12,500

 56.2011 USD

 

 5p ordinary

 CFD

 SHORT

 75,000

 56.2108 USD

 

 5p ordinary

 CFD

 SHORT

 210,000

 56.2134 USD

 

 5p ordinary

 CFD

 SHORT

 20,000

 56.2374 USD

 

 5p ordinary

 CFD

 SHORT

 5,900

 56.3442 USD

 

 5p ordinary

 CFD

 SHORT

 12,400

 56.3442 USD

 

 5p ordinary

 CFD

 SHORT

 2,553

 56.3442 USD

 

 5p ordinary

 CFD

 SHORT

 2,700

 56.3442 USD

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of

relevant security

 Product description e.g. call option

 Writing, purchasing, selling, varying etc.

 Number of securities to which option relates

 Exercise price per unit

 Type e.g. American, European etc.

 Expiry date

 Option money paid/ received per unit

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A  

 

 

(ii) Exercise

 

 Class of

relevant

security

 Product description

e.g. call option

 Exercising/

exercised

against

 Number of securities

 Exercise price

per unit

 N/A

 N/A

 N/A

 N/A

 N/A  

 

 

(d) Other dealings (including subscribing for new securities)

 

 Class of relevant security

 Nature of dealing

e.g. subscription, conversion

 Details

 Price per unit (if applicable)

 N/A

 N/A

 N/A

 N/A  

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

 (b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

 Date of disclosure:

 20 DECEMBER 2018

 

 Contact name:

 Craig Horsley

 

 Telephone number:

 +44(141) 245 7736

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEREAEAEADFPFFF
Date   Source Headline
8th Jan 20195:30 pmGNWDirector/PDMR Shareholding
8th Jan 20193:20 pmRNSForm 8.3 - Shire plc
8th Jan 20193:19 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20193:13 pmRNSForm 8.3 - Shire plc
8th Jan 20193:07 pmRNSForm 8.5 (EPT/NON-RI)
8th Jan 20192:28 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:23 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:21 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20191:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20191:27 pmRNSForm 8.3 - Shire plc
8th Jan 201912:31 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201912:29 pmRNSForm 8.3 - Takeda Pharmaceutical
8th Jan 201912:27 pmRNSForm 8.3 - Shire plc
8th Jan 201911:42 amRNSForm 8.5 (EPT/NON-RI)
8th Jan 201911:33 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
8th Jan 201910:49 amRNSForm 8.5 (EPT/RI)
8th Jan 201910:41 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201910:26 amRNSForm 8.5 (EPT/RI)- Shire plc
8th Jan 20199:51 amRNSForm 8.3 - Shire Plc
8th Jan 20198:44 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
8th Jan 20197:00 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20197:00 amGNWScheme becomes effective
7th Jan 20195:00 pmGNWHolding(s) in Company
7th Jan 20193:42 pmRNSForm 8.5 (EPT/RI) - Amendment
7th Jan 20193:20 pmRNSForm 8.3 - Shire plc
7th Jan 20193:02 pmRNSForm 8.3 - Shire plc
7th Jan 20193:00 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 20193:00 pmRNSForm 8.3 - Shire plc
7th Jan 20192:59 pmRNSForm 8.3 - Takeda Pharmaceutical
7th Jan 20192:50 pmPRNForm 8.3 - Shire Plc
7th Jan 20192:49 pmRNSForm 8.3 - Shire plc
7th Jan 20192:47 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20192:45 pmBUSForm 8.3 - Shire plc
7th Jan 20191:55 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20191:54 pmRNSForm 8.3 - Shire plc
7th Jan 20191:39 pmRNSForm 8.3 - [Shire Plc]
7th Jan 20191:32 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 20191:29 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 201912:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201912:56 pmRNSForm 8.3 - Shire plc
7th Jan 201912:42 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 201911:52 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:43 amBUSForm 8.3 - SHIRE PLC
7th Jan 201911:30 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:27 amRNSForm 8.3 - Shire plc
7th Jan 201911:01 amRNSForm 8.5 (EPT/RI)- Shire plc
7th Jan 201910:59 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
7th Jan 201910:35 amRNSForm 8.5 - Shire plc
7th Jan 201910:16 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
7th Jan 201910:13 amRNSForm 8.5 (EPT/RI) - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.